Our data indicate that METTL3 controls SLC7A11 transcription through GATA binding protein 3 (GATA3) and H3K27 lysine demethylase 6B (KDM6B), highlighting a potential approach for cancer therapy by disrupting m6A-regulated ferroptosis in cancer cells. Here, SLC7A11 is linked to cancer.